Forskolin shows promise in DMD treatment, but more research is needed
The plant-derived compound may shows therapeutic potential for DMD, but more research is needed to minimize its risks.
The plant-derived compound may shows therapeutic potential for DMD, but more research is needed to minimize its risks.
Changes to the heart’s normal function due to DMD can be caught early on using a simple, non-invasive test called a Lead II ECG.
When people with Duchenne muscular dystrophy reach adulthood, moving from child-centered healthcare to adult services comes with challenges.
New technologies are helping doctors better understand Duchenne muscular dystrophy and leading to better diagnosis and treatment options.
Virtual reality (VR) is becoming a promising tool in the rehab toolbox for people with Duchenne muscular dystrophy (DMD).
A new genetic therapy, WVE-N531, has shown promise in improving muscle health in boys with Duchenne muscular dystrophy (DMD).
Starting heart medications early in boys with Duchenne muscular dystrophy (DMD) did not prevent the heart’s decline over five years.
In Duchenne muscular dystrophy (DMD), the age when symptoms start and how quickly they get worse can be very different from person to person.
Young adults with DMD want to live meaningful, independent adult lives, but face challenges in social participation.